| Product Code: ETC7357188 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Preimplantation Genetic Screening (PGS) Technology Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Preimplantation Genetic Screening (PGS) Technology Market - Industry Life Cycle |
3.4 Greece Preimplantation Genetic Screening (PGS) Technology Market - Porter's Five Forces |
3.5 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Product and Services, 2021 & 2031F |
3.8 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.10 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Greece Preimplantation Genetic Screening (PGS) Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of preimplantation genetic screening (PGS) technology in Greece |
4.2.2 Growing demand for fertility treatments and assisted reproductive technologies in the country |
4.2.3 Technological advancements leading to improved accuracy and efficiency of PGS procedures |
4.3 Market Restraints |
4.3.1 Stringent regulations and ethical considerations related to genetic testing and manipulation |
4.3.2 High costs associated with PGS technology and procedures, limiting accessibility for some patients |
5 Greece Preimplantation Genetic Screening (PGS) Technology Market Trends |
6 Greece Preimplantation Genetic Screening (PGS) Technology Market, By Types |
6.1 Greece Preimplantation Genetic Screening (PGS) Technology Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Screening, 2021- 2031F |
6.1.4 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Diagnosis, 2021- 2031F |
6.2 Greece Preimplantation Genetic Screening (PGS) Technology Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021- 2031F |
6.2.3 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F |
6.2.4 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fluorescence in Situ Hybridization, 2021- 2031F |
6.2.5 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Comparative Genomic Hybridization, 2021- 2031F |
6.2.6 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Single-Nucleotide Polymorphism, 2021- 2031F |
6.3 Greece Preimplantation Genetic Screening (PGS) Technology Market, By Product and Services |
6.3.1 Overview and Analysis |
6.3.2 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Reagents and Consumables, 2021- 2031F |
6.3.3 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3.4 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Software and Services, 2021- 2031F |
6.4 Greece Preimplantation Genetic Screening (PGS) Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Maternity Centers, 2021- 2031F |
6.4.3 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fertility Clinics, 2021- 2031F |
6.4.4 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Hospitals, Diagnostic Labs, 2021- 2031F |
6.4.5 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Service Providers, 2021- 2031F |
6.4.6 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.4.7 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.5 Greece Preimplantation Genetic Screening (PGS) Technology Market, By Test Type |
6.5.1 Overview and Analysis |
6.5.2 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Chromosomal Abnormalities, 2021- 2031F |
6.5.3 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By X-linked Diseases, Embryo Testing, 2021- 2031F |
6.5.4 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Aneuploidy Screening, 2021- 2031F |
6.5.5 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By HLA Typing, 2021- 2031F |
6.5.6 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Other, 2021- 2031F |
6.6 Greece Preimplantation Genetic Screening (PGS) Technology Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Embryo HLA Typing for Stem Cell Therapy, 2021- 2031F |
6.6.3 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By IVF Prognosis, 2021- 2031F |
6.6.4 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Late Onset Genetic Disorders, 2021- 2031F |
6.6.5 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Inherited Genetic Disease, 2021- 2031F |
6.6.6 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Others, 2021- 2031F |
7 Greece Preimplantation Genetic Screening (PGS) Technology Market Import-Export Trade Statistics |
7.1 Greece Preimplantation Genetic Screening (PGS) Technology Market Export to Major Countries |
7.2 Greece Preimplantation Genetic Screening (PGS) Technology Market Imports from Major Countries |
8 Greece Preimplantation Genetic Screening (PGS) Technology Market Key Performance Indicators |
8.1 Rate of successful pregnancies following PGS procedures |
8.2 Adoption rate of PGS technology by fertility clinics in Greece |
8.3 Number of research and development initiatives focused on enhancing PGS technology |
9 Greece Preimplantation Genetic Screening (PGS) Technology Market - Opportunity Assessment |
9.1 Greece Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 Greece Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Greece Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Product and Services, 2021 & 2031F |
9.4 Greece Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Greece Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.6 Greece Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Greece Preimplantation Genetic Screening (PGS) Technology Market - Competitive Landscape |
10.1 Greece Preimplantation Genetic Screening (PGS) Technology Market Revenue Share, By Companies, 2024 |
10.2 Greece Preimplantation Genetic Screening (PGS) Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here